reported that silencing ST3GAL1 gene could reduce GDNF-mediated cell proliferation of BC cells in vitro, and ST3GAL1 overexpression was associated with poor clinical outcomes in BC patients with late-stage disease (31). Here, ST3GAL1 is linked to breast cancer.